Five@slrpnk.net to World News@beehaw.orgEnglish · 6 months agoOzempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5fortune.comexternal-linkmessage-square34fedilinkarrow-up1224arrow-down10cross-posted to: piracy@lemmy.dbzer0.com
arrow-up1224arrow-down1external-linkOzempic maker Novo Nordisk facing pressure as study finds $1,000 appetite suppressant can be made for just $5fortune.comFive@slrpnk.net to World News@beehaw.orgEnglish · 6 months agomessage-square34fedilinkcross-posted to: piracy@lemmy.dbzer0.com
minus-squareteawrecks@sopuli.xyzlinkfedilinkarrow-up25·6 months agoWonder how much public funding was used toward the research.
minus-squareGenEcon@lemm.eelinkfedilinkarrow-up5·6 months agoYou can look it up: https://www.novonordisk.com/partnering-and-open-innovation/open-innovation/private-public-partnerships.html
minus-squareunderisk@lemmy.mllinkfedilinkarrow-up8·edit-26 months agonothing on this page mentions anything about Ozempic, semaglutide, or the amounts of funding received. the closest thing is a list of current diabetes research projects with, again, no amounts listed and no clear relation to ozempic.
Wonder how much public funding was used toward the research.
You can look it up: https://www.novonordisk.com/partnering-and-open-innovation/open-innovation/private-public-partnerships.html
nothing on this page mentions anything about Ozempic, semaglutide, or the amounts of funding received. the closest thing is a list of current diabetes research projects with, again, no amounts listed and no clear relation to ozempic.
deleted by creator